These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Identification of molecular compounds critical to Alzheimer's-like plaque formation. Gellermann GP; Ullrich K; Unger C; Fändrich M; Sauter S; Diekmann S J Neurosci Res; 2007 Jul; 85(9):2037-44. PubMed ID: 17492785 [TBL] [Abstract][Full Text] [Related]
32. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease. Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656 [TBL] [Abstract][Full Text] [Related]
33. Structure and function of amyloid in Alzheimer's disease. Morgan C; Colombres M; Nuñez MT; Inestrosa NC Prog Neurobiol; 2004 Dec; 74(6):323-49. PubMed ID: 15649580 [TBL] [Abstract][Full Text] [Related]
34. Regression stage senile plaques in the natural course of Alzheimer's disease. Oide T; Kinoshita T; Arima K Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888 [TBL] [Abstract][Full Text] [Related]
35. Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation. Johansson AS; Bergquist J; Volbracht C; Päiviö A; Leist M; Lannfelt L; Westlind-Danielsson A Neuroreport; 2007 Apr; 18(6):559-63. PubMed ID: 17413657 [TBL] [Abstract][Full Text] [Related]
36. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains. Welander H; Frånberg J; Graff C; Sundström E; Winblad B; Tjernberg LO J Neurochem; 2009 Jul; 110(2):697-706. PubMed ID: 19457079 [TBL] [Abstract][Full Text] [Related]
37. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Esler WP; Stimson ER; Ghilardi JR; Lu YA; Felix AM; Vinters HV; Mantyh PW; Lee JP; Maggio JE Biochemistry; 1996 Nov; 35(44):13914-21. PubMed ID: 8909288 [TBL] [Abstract][Full Text] [Related]
38. Amyloid-like formation by self-assembly of peptidolipids in two dimensions. Li C; Orbulescu J; Sui G; Leblanc RM Langmuir; 2004 Sep; 20(20):8641-5. PubMed ID: 15379486 [TBL] [Abstract][Full Text] [Related]
39. Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin. Gellermann GP; Ullrich K; Tannert A; Unger C; Habicht G; Sauter SR; Hortschansky P; Horn U; Möllmann U; Decker M; Lehmann J; Fändrich M J Mol Biol; 2006 Jul; 360(2):251-7. PubMed ID: 16765377 [TBL] [Abstract][Full Text] [Related]
40. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes. Hüll M; Müksch B; Akundi RS; Waschbisch A; Hoozemans JJ; Veerhuis R; Fiebich BL Neurochem Int; 2006 Jun; 48(8):663-72. PubMed ID: 16546299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]